首页> 外文期刊>European journal of gastroenterology and hepatology >Cost-effectiveness of colorectal cancer screening with computed tomography colonography according to a polyp size threshold for polypectomy.
【24h】

Cost-effectiveness of colorectal cancer screening with computed tomography colonography according to a polyp size threshold for polypectomy.

机译:根据结肠息肉切除术的息肉大小阈值,使用计算机断层扫描结肠摄影术筛查结直肠癌的成本效益。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: Computed tomography colonography (CTC) has an acceptable accuracy in detecting colonic lesions, especially for polyps at least 6 mm. The aim of this analysis is to determine the cost-effectiveness of population-based screening for colorectal cancer (CRC) using CTC with a polyp size threshold. METHODS: The cost-effectiveness ratios of CTC performed at 50, 60 and 70 years old, without (PL strategy) or with (TS strategy) polyp size threshold were compared using a Markov process. Incremental cost-effectiveness ratios (ICER) were calculated per life-years gained (LYG) for a time horizon of 30 years. RESULTS: The ICER of PL and TS strategies were 12 042 and 2765 euro/LYG associated to CRC prevention rates of 37.9 and 36.5%. The ICER of PL and TS strategies dropped to 9687 and 1857 euro/LYG when advanced adenoma (AA) prevalence increased from 6.9 to 8.6% for male participants and 3.8-4.9% for female participants or to 9482 and 2067 euro/LYG when adenoma and AA annual recurrence rates dropped to 3.2 and 0.25%. The ICER for PL and TS strategies decreased to 7947 and 954 euro/LYG or when only two CTC were performed at 50 and 60-years-old. Conversely, the ICER did not significantly change when varying population participation rate or accuracy of CTC. CONCLUSION: CTC with a 6 mm threshold for polypectomy is associated to a substantial cost reduction without significant loss of efficacy. Cost-effectiveness depends more on the AA prevalence or transition rate to CRC than on CTC accuracy or screening compliance.
机译:目的:计算机断层扫描结肠造影(CTC)在检测结肠病变方面具有可接受的准确性,尤其是对于至少6 mm的息肉。本分析的目的是确定使用具有息肉大小阈值的CTC进行人群筛查结直肠癌(CRC)的成本效益。方法:使用马尔可夫过程比较了在50、60和70岁时(没有PL策略)或(TS策略)息肉大小阈值的情况下进行CTC的成本-效果比。在30年的时间范围内,每获得的生命年(LYG)计算增量成本效益比(ICER)。结果:PL和TS策略的ICER为12042和2765 euro / LYG,与CRC预防率分别为37.9和36.5%。当晚期腺瘤(AA)患病率从男性参与者的6.9%上升到8.6%,女性参与者的3.8-4.9%时,PL和TS策略的ICER下降至9687和1857欧元/ LYG,而当腺瘤和结直肠癌的发生率从9482和2067欧元/ LYG下降机管局的年复发率降至3.2和0.25%。 PL和TS策略的ICER降至7947和954欧元/ LYG,或者在50和60岁时仅执行了两次CTC。相反,当改变人口参与率或反恐委员会的准确性时,ICER并没有显着变化。结论:息肉切除术阈值为6 mm的CTC可以显着降低成本,而不会显着降低疗效。成本效益更多地取决于AA患病率或向CRC的转化率,而不是CTC准确性或筛查依从性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号